Literature DB >> 10588765

Impairment of natural killer cell activity in Chlamydia trachomatis infected individuals.

E Mavoungou1, V Poaty-Mavoungou, F S Touré, A Sall, A Delicat, P Yaba, Y Mandeme, R Nabias, J Lansoud-Soukate.   

Abstract

Natural killer (NK) cell activity is impaired in Chlamydia trachomatis-infected patients. The mechanisms behind the altered NK functions are not clear, but data concerning NK and antibody-dependent cellular cytotoxicity (ADCC) activity have been reported. To investigate whether this impairment is related to a defect at the target cell binding and/or the postbinding level, we evaluated highly purified NK cells obtained from 125 C. trachomatis-infected patients and compared them with 101 normal controls for their ability to kill K-562 and U-937 cell lines using a 51Cr release assay; release tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma); and kill anti-IgM preincubated P-815 cell line (ADCC activity). We found a decrease in the lytic capability of NK cells from C. trachomatis-infected patients against target cell lines; decreased ability to kill bound target cells; and low levels of released TNF-alpha and INF-gamma after incubation with U-937 cells. Taken together, these findings suggest that the impaired NK cell reaction during chlamydial infection is related to defects both at the target and postbinding levels. However, the precise mechanisms remain to be determined. The inability to restore normal NK activity after long-term culture in the presence of high levels of recombinant IL-2 support the hypothesis of an anergic process during chlamydial infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588765     DOI: 10.1046/j.1365-3156.1999.00479.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  8 in total

1.  Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour.

Authors:  V Verhoeven; M Baay; J Weyler; D Avonts; F Lardon; P Van Royen; J B Vermorken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-18       Impact factor: 3.267

2.  Modulation of MICA on the surface of Chlamydia trachomatis-infected endocervical epithelial cells promotes NK cell-mediated killing.

Authors:  Joyce Altamarino Ibana; Ashok Aiyar; Alison Jane Quayle; Danny Joseph Schust
Journal:  FEMS Immunol Med Microbiol       Date:  2012-02-16

3.  Differential modulating effect of natural killer (NK) T cells on interferon-γ production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection.

Authors:  Lei Zhao; Xiaoling Gao; Ying Peng; Antony G Joyee; Hong Bai; Shuhe Wang; Jie Yang; Weiming Zhao; Xi Yang
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

4.  Stimulated peripheral blood mononuclear cells from chlamydia-infected women release predominantly Th1-polarizing cytokines.

Authors:  Stephen J Jordan; Rakesh K Bakshi; LaDraka' T Brown; Xiaofei Chi; William M Geisler
Journal:  Cytokine       Date:  2018-06-18       Impact factor: 3.861

5.  Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites.

Authors:  Elizabeth G Kane; Andrew W Taylor-Robinson
Journal:  Malar Res Treat       Date:  2012-01-18

6.  NK Cell-Mediated Processing Of Chlamydia psittaci Drives Potent Anti-Bacterial Th1 Immunity.

Authors:  Nadine Radomski; Kati Franzke; Svea Matthiesen; Axel Karger; Michael R Knittler
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

7.  NK cell compartment in patients with coronary heart disease.

Authors:  Łukasz Hak; Jolanta Myśliwska; Joanna Więckiewicz; Krzysztof Szyndler; Piotr Trzonkowski; Janusz Siebert; Andrzej Myśliwski
Journal:  Immun Ageing       Date:  2007-05-08       Impact factor: 6.400

Review 8.  An Ancient Molecular Arms Race: Chlamydia vs. Membrane Attack Complex/Perforin (MACPF) Domain Proteins.

Authors:  Gabrielle Keb; Kenneth A Fields
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.